• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Agios Pharmaceuticals (NQ: AGIO )

    47.09 +0.54 (+1.16%)
    Streaming Delayed Price Updated: 9:41 AM EDT, Sep 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 16,192
    Open 46.85
    Bid (Size) 46.55 (4)
    Ask (Size) 47.38 (4)
    Prev. Close 46.55
    Today's Range 46.74 - 47.44
    52wk Range 19.80 - 50.35
    Shares Outstanding 58,951,469
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides
    Agios Pharmaceuticals' Phase 3 ACTIVATE-KidsT study results reveal that mitapivat achieved a 28.1% transfusion reduction in children with PK deficiency compared to 11.8% with placebo. Secondary... 
    Via Benzinga
    Expert Ratings For Agios Pharmaceuticals
    Via Benzinga

    Performance

    YTD
    +106.26%
    +106.26%
    1 Month
    +1.88%
    +1.88%
    3 Month
    +4.11%
    +4.11%
    6 Month
    +58.66%
    +58.66%
    1 Year
    +92.91%
    +92.91%

    More News

    Read More
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
    Via Benzinga
    Earnings Scheduled For February 15, 2024
    Via Benzinga
    Earnings Preview: Agios Pharmaceuticals
    Via Benzinga
    RBC Capital Maintains Outperform Rating for Agios Pharmaceuticals: Here's What You Need To Know
    Via Benzinga
    June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge
    Via InvestorPlace
    Why Is Agios Pharmaceuticals Stock Trading Higher On Monday?
    Via Benzinga
    Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Nvidia Again Boosts Nasdaq To Record Highs
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why Is Agios Pharmaceuticals Stock Trading Higher On Tuesday?
    Via Benzinga
    Exposures Product Safety
    Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Agios Pharmaceuticals Inks $905 Million Deal For Cancer Drug; Shares Poised To Break Out
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Attention Biotech Investors - Stocks To Watch
    Via Benzinga
    AGIO Stock Earnings: Agios Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    The 3 Best Biotech Stocks to Buy Now: Q2 Edition
    Via InvestorPlace
    Agios Pharmaceuticals Stock Earns RS Rating Upgrade; Hits Key Benchmark
    Via Investor's Business Daily
    7 Biotech Stocks Fighting America’s Deadliest Diseases
    Via InvestorPlace
    Why Is Blood Disorder Focused Agios Pharmaceuticals Stock Trading Higher Today?
    Via Benzinga
    Agios Pharma Surges, And Retakes Its 200-Day Line, On Promising Test Results For Thalassemia Drug
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.